Toxicity of peptides of Amanita virosa mushrooms in mice. 1985

A Loranger, and B Tuchweber, and C Gicquaud, and S St-Pierre, and M G Côté

A study was performed on the hepatic reaction of mice to acute intoxication with virotoxins (alaviroidin, viroisin, deoxoviroisin, viroidin, deoxoviroidin) and phalloidin, cyclic peptides isolated from Amanita virosa mushrooms. Purified fractions were administered intraperitoneally at various dosages to determine the LD50 which ranged from 1.0 to 5.3 mg/kg, with viroidin, phalloidin, and viroisin being the most potent. The virotoxins and phalloidin induced hemorrhagic necrosis of the liver. The development of hepatic lesions was followed by enhanced serum alanine aminotransferase (ALT) activity as well as by light and electron microscopic changes. In additional groups, bile ducts were cannulated and bile was collected for 2 hr after injection of the peptides (1 mg/kg) to determine their cholestatic potential. The earliest changes in hepatocytes were plasma membrane invagination and cytoplasmic vacuole formation. At later time periods, erythrocyte accumulation was evident in vacuoles and in the cytoplasm. The severity of hepatic damage, as judged by morphologic analysis, was correlated with serum ALT activity. Two of the peptides tested (viroisin and phalloidin) decreased bile flow by more than 50% over control values. Mild ultrastructural alterations in the bile canalicular pole of hepatocytes were observed during the development of cholestasis. Since virotoxins, like phalloidin, are bound to actin, it is possible that their affinity to cellular actin may be responsible for their hepatotoxicity.

UI MeSH Term Description Entries
D007928 Lethal Dose 50 The dose amount of poisonous or toxic substance or dose of ionizing radiation required to kill 50% of the tested population. LD50,Dose 50, Lethal
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D009842 Oligopeptides Peptides composed of between two and twelve amino acids. Oligopeptide
D009929 Organ Size The measurement of an organ in volume, mass, or heaviness. Organ Volume,Organ Weight,Size, Organ,Weight, Organ
D010456 Peptides, Cyclic Peptides whose amino acid residues are linked together forming a circular chain. Some of them are ANTI-INFECTIVE AGENTS; some are biosynthesized non-ribosomally (PEPTIDE BIOSYNTHESIS, NON-RIBOSOMAL). Circular Peptide,Cyclic Peptide,Cyclic Peptides,Cyclopeptide,Orbitide,Circular Peptides,Cyclopeptides,Orbitides,Peptide, Circular,Peptide, Cyclic,Peptides, Circular
D010590 Phalloidine Very toxic polypeptide isolated mainly from AMANITA phalloides (Agaricaceae) or death cup; causes fatal liver, kidney and CNS damage in mushroom poisoning; used in the study of liver damage. Phalloidin
D005260 Female Females
D005704 Gallbladder A storage reservoir for BILE secretion. Gallbladder allows the delivery of bile acids at a high concentration and in a controlled manner, via the CYSTIC DUCT to the DUODENUM, for degradation of dietary lipid. Gallbladders
D000363 Agaricales An extensive order of basidiomycetous fungi whose fruiting bodies are commonly called mushrooms. Agaricaceae,Mushrooms,Agaricale,Mushroom
D000410 Alanine Transaminase An enzyme that catalyzes the conversion of L-alanine and 2-oxoglutarate to pyruvate and L-glutamate. (From Enzyme Nomenclature, 1992) EC 2.6.1.2. Alanine Aminotransferase,Glutamic-Pyruvic Transaminase,SGPT,Alanine-2-Oxoglutarate Aminotransferase,Glutamic-Alanine Transaminase,Alanine 2 Oxoglutarate Aminotransferase,Aminotransferase, Alanine,Aminotransferase, Alanine-2-Oxoglutarate,Glutamic Alanine Transaminase,Glutamic Pyruvic Transaminase,Transaminase, Alanine,Transaminase, Glutamic-Alanine,Transaminase, Glutamic-Pyruvic

Related Publications

A Loranger, and B Tuchweber, and C Gicquaud, and S St-Pierre, and M G Côté
July 1980, Biochemistry,
A Loranger, and B Tuchweber, and C Gicquaud, and S St-Pierre, and M G Côté
January 1980, Experientia,
A Loranger, and B Tuchweber, and C Gicquaud, and S St-Pierre, and M G Côté
November 1998, Wei sheng yan jiu = Journal of hygiene research,
A Loranger, and B Tuchweber, and C Gicquaud, and S St-Pierre, and M G Côté
May 1980, Proceedings of the National Academy of Sciences of the United States of America,
A Loranger, and B Tuchweber, and C Gicquaud, and S St-Pierre, and M G Côté
September 1983, International journal of peptide and protein research,
A Loranger, and B Tuchweber, and C Gicquaud, and S St-Pierre, and M G Côté
June 1994, Anales de medicina interna (Madrid, Spain : 1984),
A Loranger, and B Tuchweber, and C Gicquaud, and S St-Pierre, and M G Côté
December 1957, Minerva farmaceutica,
A Loranger, and B Tuchweber, and C Gicquaud, and S St-Pierre, and M G Côté
November 2012, Natural product communications,
A Loranger, and B Tuchweber, and C Gicquaud, and S St-Pierre, and M G Côté
February 1957, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
A Loranger, and B Tuchweber, and C Gicquaud, and S St-Pierre, and M G Côté
October 1957, Minerva medica,
Copied contents to your clipboard!